sunitinib fmk 50 mg tvrdé kapsuly
farmak international sp. z o.o., poľsko - sunitinib - 44 - cytostatica
sunitinib fmk 25 mg tvrdé kapsuly
farmak international sp. z o.o., poľsko - sunitinib - 44 - cytostatica
sunitinib fmk 12,5 mg tvrdé kapsuly
farmak international sp. z o.o., poľsko - sunitinib - 44 - cytostatica
zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
dutasterid/tamsulozín fmk
farmak international sp. z o.o., poľsko - tamsulozín a dutasterid - 77 - sympatholytica
tadalafil fmk 2,5 mg
farmak international sp. z o.o., poľsko - tadalafil - 83 - vasodilatantia
tadalafil fmk 20 mg
farmak international sp. z o.o., poľsko - tadalafil - 83 - vasodilatantia
tadalafil fmk 10 mg
farmak international sp. z o.o., poľsko - tadalafil - 83 - vasodilatantia
tadalafil fmk 5 mg
farmak international sp. z o.o., poľsko - tadalafil - 83 - vasodilatantia
tegretol 2 %
novartis s.r.o. - karbamazepín - 21 - antiepileptica, anticonvulsiva